Back
Royal Bank of Canada Vs. Denali Therapeutics Industry Stock Comparison
Buy
65
RY
Royal Bank of Canada
Last Price:
122.97
Seasonality Move:
2.76%
Buy
56
DNLI
Denali Therapeutics
Last Price:
31.20
Seasonality Move:
17.79%
Buy
65
Royal Bank of Canada (RY)
is a Buy
Is Royal Bank of Canada a Buy, Sell or Hold?
- The current Royal Bank of Canada [RY] share price is $122.56. The Score for RY is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- RY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.76. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RY Stock Price Chart
What is Royal Bank of Canada's stock price today?
-
The Royal Bank of Canada share price today is $122.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RY is experiencing slight selling pressure.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
RY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.97 | Buy |
Relative Strength Index (14 RSI): | 69.06 | Buy |
Chaikin Money Flow: | -209910 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.84 - 123.04) | Buy |
Bollinger Bands (100): | (103.02 - 115.96) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.79 | Buy |
Relative Strength Index (14 RSI): | 78.12 | Buy |
Chaikin Money Flow: | -939708 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.39 - 28.19) | Buy |
Bollinger Bands (100): | (19.07 - 25.27) | Buy |
RY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 123.1 | Sell |
20-day SMA: | 120.14 | Buy |
50-day SMA: | 114.18 | Buy |
200-day SMA: | 103.93 | Buy |
8-day EMA: | 122.61 | Sell |
20-day EMA: | 120.09 | Buy |
50-day EMA: | 115.32 | Buy |
200-day EMA: | 105.54 | Buy |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.69 | Buy |
20-day SMA: | 26.4 | Buy |
50-day SMA: | 24.37 | Buy |
200-day SMA: | 20.59 | Buy |
8-day EMA: | 29.03 | Buy |
20-day EMA: | 26.97 | Buy |
50-day EMA: | 24.8 | Buy |
200-day EMA: | 22.21 | Buy |
Royal Bank of Canada Earnings Growth & RY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.18 per share, an increase this year of $0.64 per share, and an increase next year of $0.55 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Royal Bank of Canada Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |